iSpecimen (ISPC)
NASDAQ:ISPC
ISPC Stock Chart & Stats
$0.31
-$0.03(-1.03%)
At close: 4:00 PM EST
$0.31
-$0.03(-1.03%)
Day’s Range― - ―
52-Week Range$0.10 - $3.18
Previous CloseN/A
Volume25.67K
Average Volume (3M)8.88M
Market Cap
$3.80M
Enterprise Value-$6.01M
Total Cash (Recent Filing)$6.88M
Total Debt (Recent Filing)$268.80K
Price to Earnings (P/E)―
Beta1.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding29,662,250
10 Day Avg. Volume698,577
30 Day Avg. Volume8,882,166
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.39
Price to Sales (P/S)0.62
P/FCF Ratio-0.28
Enterprise Value/Market Cap-1.58
Enterprise Value/Revenue-3.11
Enterprise Value/Gross Profit-249.13
Enterprise Value/Ebitda0.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageLow debt-to-equity provides structural balance-sheet flexibility, reducing fixed financing costs and preserving optionality for capital raises or partnership investments. This gives the business room to fund digital and operational initiatives without heavy interest burdens over the next several months.
Digital Marketplace TransformationA fully integrated, AI-assisted marketplace is a durable operational upgrade: it should lower marginal costs, speed supplier onboarding, improve matching efficiency, and scale revenue per platform user. Over 2–6 months this meaningfully enhances unit economics and execution capability.
Streamlined Global Shipping & PartnershipsDirect shipment model and deeper European sourcing partnerships materially improve service reliability and access to rare specimens. Faster, cheaper logistics strengthens the platform's value proposition and competitiveness for global research customers on a sustained basis.
Bears Say
Revenue Decline And Margin CollapseA sharp drop in revenue combined with a collapse in gross margin signals structural weakening of core marketplace economics. Sustaining growth or reinvesting in product/operations will be difficult if revenue base and gross profitability do not recover, threatening long-term viability.
Persistent Negative Cash GenerationConsistent negative OCF and worsening FCF erode reserves and limit organic funding of operations or platform investments. Over months this raises the likelihood of dilutive financings or cutbacks, constraining the company's ability to execute strategic initiatives and stabilize operations.
Governance / Shareholder Engagement IssuesOngoing quorum failures indicate weak shareholder engagement and create risk of delayed approvals for governance, compensation, or strategic transactions. This governance friction can impede timely board-led decisions and complicate access to capital or partnerships over the near term.
iSpecimen News
ISPC FAQ
What was iSpecimen’s price range in the past 12 months?
iSpecimen lowest stock price was $0.10 and its highest was $3.18 in the past 12 months.
What is iSpecimen’s market cap?
iSpecimen’s market cap is $3.80M.
When is iSpecimen’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were iSpecimen’s earnings last quarter?
Currently, no data Available
Is iSpecimen overvalued?
According to Wall Street analysts iSpecimen’s price is currently Overvalued.
Does iSpecimen pay dividends?
iSpecimen does not currently pay dividends.
What is iSpecimen’s EPS estimate?
iSpecimen’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iSpecimen have?
iSpecimen has 29,662,250 shares outstanding.
What happened to iSpecimen’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of iSpecimen?
Currently, no hedge funds are holding shares in ISPC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
iSpecimen
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Technical Analysis
―
Intelligent Bio Solutions
―
BioNexus Gene Lab Corp
―
―
bioAffinity Technologies, Inc.
―
Ownership Overview
―
Insiders
0.43% Mutual Funds
<0.01% Other Institutional Investors
99.56% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---